481 Highly efficient methane biocatalysis revealed in a methanotrophic bacterium.
http://www.nature.com/ncomms/2013/131203/ncomms3785/full/ncomms3785.html
480 Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
http://www.nature.com/nature/journal/v503/n7477/full/nature12711.html
479 Identical bacteria can have low-level resistance to low concentrations of drugs that can flip subpopulations into dormancy.
http://www.sciencemag.org/content/342/6162/1237435.abstract
478 Bactericidal activity of black silicon.
http://www.nature.com/ncomms/2013/131126/ncomms3838/full/ncomms3838.html
477 IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication.
http://www.pnas.org/content/110/48/E4571.abstract
476 HIV-1 evades innate immune recognition through specific cofactor recruitment.
http://www.nature.com/nature/journal/v503/n7476/full/nature12769.html
475 Staphylococcus δ-toxin induces allergic skin disease by activating mast cells.
http://www.nature.com/nature/journal/v503/n7476/full/nature12655.html
474 Activated ClpP kills persisters and eradicates a chronic biofilm infection.
http://www.nature.com/nature/journal/v503/n7476/full/nature12790.html
473 A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence.
http://www.pnas.org/content/110/47/19095.abstract
472 MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells.
http://www.pnas.org/content/110/47/19083.abstract
|
